Home > Insider Trading > Filing (0001562180-19-003055)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1404281	Novus Therapeutics Inc.	NVUS	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1705278	C. Catherine Turkel	C/O Novus Therapeutics, Inc. 19900 Macarthur Blvd., Suite 550 Irvine CA 92612	President	No	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2019-05-20	7,623	$1.96	90,576	No	4	S	Direct
Common Stock	Disposition	2019-05-21	1,914	$1.91	88,662	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	S	Direct

Footnotes

Shares were sold to cover the reporting person's taxes due on the vesting of restricted stock units.
This transaction was executed in multiple trades at prices ranging from $1.90 to $2.05. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $1.90 to $1.945. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.